Increasing [3H]thymidine labelling index (LI) during therapy is necessary for cure of acute myelocytic leukemia (AML) with one cycle of times sequential chemotherapy (TSC)

W. P. Vaughan, J. E. Karp, R. J. Burke

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Increasing [3H]thymidine labelling index (LI) during therapy is necessary for cure of acute myelocytic leukemia (AML) with one cycle of times sequential chemotherapy (TSC)'. Together they form a unique fingerprint.